P Marsalek

1 ta ish

Eli Lilly (Germany)

1. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study

   Arya M. Sharma, Todd H. Wagner, P Marsalek

   Maqola20042 iqtibos

   ABIABI:AkademIndex/2026.other.295705